This inventor holds 3 USPTO granted patents. Top assignee: Applera Corporation. Active years: 2004-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2005
Title: William Rowe: Innovator in Genetic Research
Introduction
William Rowe is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of genetic research, particularly in understanding polymorphisms associated with various diseases. With a total of 3 patents, Rowe's work has implications for both diagnostics and therapeutic approaches in medicine.
Latest Patents
Rowe's latest patents include groundbreaking discoveries in the realm of inflammatory autoimmune diseases and osteoporosis. The first patent focuses on novel polymorphisms (SNPs) in genes that contribute to inflammatory and autoimmune disorders. This invention provides reagents for detecting and expressing variant nucleic acid/protein sequences, as well as methods for identifying and utilizing these variants. The second patent addresses polymorphisms associated with osteoporosis, offering similar methodologies for detection and application in understanding this condition.
Career Highlights
William Rowe is affiliated with Applera Corporation, where he has been instrumental in advancing genetic research. His work has not only expanded the scientific community's understanding of genetic variations but has also paved the way for potential new treatments for autoimmune diseases and osteoporosis.
Collaborations
Rowe has collaborated with notable scientists in the field, including J Craig Venter and Jinghui N Zhang. These partnerships have further enriched his research and contributed to the advancement of genetic studies.
Conclusion
William Rowe's innovative work in genetic research highlights the importance of understanding polymorphisms in relation to health conditions. His contributions continue to influence the field and offer hope for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
